Identification and Visualization of CD8⁺ T Cell Mediated IFN-γ Signaling in Target Cells during an Antiviral Immune Response in the Brain

• Mariana Puntel,

  Current address: Laboratory for Regenerative and Protective Therapies of the Nervous System, Institute Leloir Foundation-IIBBA-National Council for Scientific and Technical Research, Buenos Aires, Argentina

  Affiliation Board of Governors' Gene Therapeutics Research Institute, Cedars-Sinai Medical Center, Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Robert Barrett,

  Affiliation Board of Governors' Gene Therapeutics Research Institute, Cedars-Sinai Medical Center, Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Nicholas S. R. Sanderson,

  Current address: Departments of Neurosurgery, and Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America

  Affiliation Board of Governors' Gene Therapeutics Research Institute, Cedars-Sinai Medical Center, Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Kurt M. Kroeger,

  Current address: Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

  Affiliation Board of Governors' Gene Therapeutics Research Institute, Cedars-Sinai Medical Center, Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Niyati Bondale,

  Affiliation Board of Governors' Gene Therapeutics Research Institute, Cedars-Sinai Medical Center, Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Mia Wibowo,

  Affiliation Board of Governors' Gene Therapeutics Research Institute, Cedars-Sinai Medical Center, Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Sean Kennedy,

  Affiliation Board of Governors' Gene Therapeutics Research Institute, Cedars-Sinai Medical Center, Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Chunyan Liu,

  Affiliation Board of Governors' Gene Therapeutics Research Institute, Cedars-Sinai Medical Center, Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Maria G. Castro,

  Current address: Departments of Neurosurgery, and Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America

  Affiliation Board of Governors' Gene Therapeutics Research Institute, Cedars-Sinai Medical Center, Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Pedro R. Lowenstein

  * E-mail: pedrol@umich.edu

  Affiliation Board of Governors' Gene Therapeutics Research Institute, Cedars-Sinai Medical Center, Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

  ⨯